http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101738200-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-245 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate | 2010-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101738200-B1 |
| titleOfInvention | Transdermal preparation containing basic anti-inflammatory agent |
| abstract | The present invention provides a transdermal therapeutic preparation comprising a basic antiinflammatory agent and a basic antiinflammatory agent, which does not inhibit the physical properties of a solid and exhibits excellent drug releasing properties. It does not inhibit the release of a local anesthetic agent, Wherein the basic antiinflammatory agent is a transdermal patch, characterized in that it contains both a basic antiinflammatory agent and a local anesthetic agent as an absorption promoting agent for the basic antiinflammatory agent. The basic antiinflammatory agent has an acid dissociation constant (pKa) of 7 or more , The content of the basic anti-inflammatory analgesic agent is 0.1 to 10% by weight based on the total weight of the drug-containing solid, and the content of the absorption enhancer is 0.01 to 20% by weight based on the total weight of the drug-containing solid. |
| priorityDate | 2009-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.